AstraZeneca Pharma India has secured approval for Durvalumab. This drug, combined with chemotherapy, will treat gastric and gastroesophagea...

New data from Europe's biggest oncology meeting reveals a high-stakes race for patients with a tough breast cancer. Astra and Daiichi's Dat...

At the Christie hospital in Manchester, medical professionals are currently overseeing approximately 30 clinical trials. Encouragingly, the...

Drug firm AstraZeneca India on Friday said it has received approval from the domestic drug regulator to market a drug to treat biliary trac...

CAR-T therapies, previously not available in India, have shown promising results for patients who have exhausted all other means of treatme...

The early results from the IMAGINE study were based on the first 10 patients of the planned 24 patients to be enrolled.Both adult and child...

The Mediterranean diet will play an important role in the success of immunotherapy.

You cannot avoid pollen entirely, but there are ways to prevent symptoms.

Chemotherapy for decades was considered “the rule, the dogma,” for treating cancer, but various data offer some confirmation that the metho...

Patients with cancer were excluded from the clinical trials for the Covid vaccines.

Taking cue from the WHO’s revised list of essential medicines, popular biosimilars for cancer cure may get incorporated in India’s revised ...

Immunotherapy should be given as early as possible to achieve a lasting remission of the disease.

Tokyo, Aug 26 (IANS) Japanese researchers have developed an antibody that induces immune responses, which significantly suppresses malignan...

These nanoparticles are then loaded into microneedles, which are arrayed on the surface of a patch. When the patch is applied to a melanoma...

A next-generation cell-based immunotherapy may offer new hope in the fight against the most aggressive form of brain cancer.

Schwan says India’s healthcare spend relative to GDP is very low, compared to economies such as China which spends about 5% to 6% of its GD...

New and considerable optimism over cancer drugs will drive deal-making in pharma over the decade, with companies weak in this segment tryin...